THE INHIBITION OF JAK/STAT SIGNALING IS COMPENSATED BY ACTIVATION OF MAPK PATHWAY IN MYELOPROLIFERATIVE NEOPLASMS

被引：0
|
作者：
Suboticki, T. [1 ]
Cokic, B. Beleslin [2 ]
Djikic, D. [1 ]
Mojsilovic, S. [3 ]
Sefer, D. [4 ]
Bjelica, S. [3 ]
Santibanez, J. [3 ]
Cokic, V. [3 ]
机构：
[1] Univ Belgrade, Inst Med Res, Lab Neuroendocrinol, Belgrade, Serbia
[2] Clin Ctr Serbia, Clin Endocrinol Diabet & Metab Dis, Belgrade, Serbia
[3] Univ Belgrade, Inst Med Res, Lab Expt Hematol, Belgrade, Serbia
[4] Clin Ctr Serbia, Clin Hematol, Belgrade, Serbia
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1308
引用
收藏
页码：536 / 537
页数：2
相关论文
共 50 条
  • [21] Inhibition of cytokines and JAK-STAT activation by distinct signaling pathways
    Sengupta, TK
    Schmitt, EM
    Ivashkiv, LB
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (18) : 9499 - 9504
  • [22] REGULATION OF THE JAK STAT SIGNALING PATHWAY
    FINBLOOM, DS
    LARNER, AC
    CELLULAR SIGNALLING, 1995, 7 (08) : 739 - 745
  • [23] JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms
    Maslah, N.
    Roux, B.
    Kaci, N.
    Verger, E.
    De Oliveira, R. Daltro
    Pasquer, H.
    Zhao, L. P.
    Gauthier, N.
    Soret-Dulphy, J.
    Ganesan, S.
    Gou, P.
    Ling, F.
    Parquet, N.
    Vainchenker, W.
    Raffoux, E.
    Padua, R. A.
    Giraudier, S.
    Puissant, A.
    Lobry, C.
    Kiladjian, J. J.
    Cassinat, B.
    Benajiba, L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 11 - 11
  • [24] PROINFLAMMATORY CYTOKINE IL-6 STIMULATION OF ANGIOGENIC FACTORS AND DNA REPLICATION IS BLOCKED BY JAK-STAT PATHWAY INHIBITION IN MYELOPROLIFERATIVE NEOPLASMS
    Suboticki, T.
    Cokic, B. Beleslin
    Lekovic, D.
    Mojsilovic, S.
    Ajtic, O. Mitrovic
    Kovacic, M.
    Diklic, M.
    Gotic, M.
    Cokic, V.
    HAEMATOLOGICA, 2017, 102 : 540 - 541
  • [25] JAK Inhibition Impairs NK Cell Function in Myeloproliferative Neoplasms
    Schoenberg, Kathrin
    Rudolph, Janna
    Vonnahme, Maria
    Yajnanarayana, Sowmya Parampalli
    Cornez, Isabelle
    Hejazi, Maryam
    Manser, Angela R.
    Uhrberg, Markus
    Verbeek, Walter
    Koschmieder, Steffen
    Bruemmendorf, Tim H.
    Brossart, Peter
    Heine, Annkristin
    Wolf, Dominik
    CANCER RESEARCH, 2015, 75 (11) : 2187 - 2199
  • [26] Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms
    Oh, Stephen T.
    Simonds, Erin F.
    Jones, Carol
    Hale, Matthew B.
    Goltsev, Yury
    Gibbs, Kenneth D., Jr.
    Merker, Jason D.
    Zehnder, James L.
    Nolan, Garry P.
    Gotlib, Jason
    BLOOD, 2010, 116 (06) : 988 - 992
  • [27] The involvement of Galectins in the modulation of the JAK/STAT pathway in myeloproliferative neoplasia
    Koopmans, Suzanne M.
    Bot, Freek J.
    Schouten, Harry C.
    Janssen, Jannie
    van Marion, Arienne M. W.
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2012, 2 (02): : 119 - 127
  • [28] Effect of (-)-Epigallocatechin Gallate on Activation of JAK/STAT Signaling Pathway by Staphylococcal Enterotoxin A
    Shimamura, Yuko
    Noaki, Rina
    Kurokawa, Ami
    Utsumi, Mio
    Hirai, Chikako
    Kan, Toshiyuki
    Masuda, Shuichi
    TOXINS, 2021, 13 (09)
  • [29] The JAK- STAT Signaling Pathway in Epilepsy
    Sun, Huaiyu
    Ma, Di
    Cheng, Yu
    Li, Jiaai
    Zhang, Wuqiong
    Jiang, Ting
    Li, Zhaoran
    Li, Xuewei
    Meng, Hongmei
    CURRENT NEUROPHARMACOLOGY, 2023, 21 (10) : 2049 - 2069
  • [30] Pharmaceutical intervention in the JAK/STAT signaling pathway
    H Martin Seidel
    Peter Lamb
    Jonathan Rosen
    Oncogene, 2000, 19 : 2645 - 2656
12345